Loading clinical trials...
Loading clinical trials...
Efficacy of Lidocaine in Decreasing Perioperative Analgesic Opioids Requirement After Ambulatory Surgery
1. \*Reduced opioid consumption 2. \*Decreased pain scores 3. \*Fewer opioid-related side effects 4. \*Improved patient satisfaction
Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period. Studies have shown that lidocaine can reduce opioid consumption by 20-50% in the perioperative period. By reducing opioid consumption, lidocaine can also decrease the incidence of opioid-related side effects, such as nausea, vomiting, and respiratory depression. Lidocaine's analgesic effects can improve patient satisfaction and reduce anxiety related to pain
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
Liaquat National Hospital and Medical College
Karachi, Sindh, Pakistan
Start Date
November 5, 2023
Primary Completion Date
May 10, 2024
Completion Date
May 10, 2024
Last Updated
December 10, 2024
80
ACTUAL participants
Lidocaine 2% without vessel constrictor
DRUG
Normal Saline
DRUG
Lead Sponsor
Liaquat National Hospital & Medical College
NCT06346132
NCT07482709
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07351968